Showing results (1-10 of 91) with videos related to
Sort By:
Pageof 10
Apoptosis : an International Journal on Programmed Cell Death|January 24, 2004
SiRNA based strategies for inhibition of apoptotic pathways in vivo--analytical and therapeutic implicationsL Zender, S KubickaDer Internist|November 9, 2016
[Diagnostics and treatment of cholangiocellular carcinoma]L Zender, N P MalekDer Internist|January 16, 2020
[Personalized treatment of cholangiocellular carcinoma (CCA)]L Jödicke, L Zender, N P MalekDer Internist|December 21, 2006
[Systemic treatment of liver and biliary tumors]N P Malek, T Greten, S KubickaJournal of Molecular Biology|June 12, 2001
Autoregulation enables different pathways to control CCAAT/enhancer binding protein beta (C/EBP beta) transcriptionM Niehof, S Kubicka, L Zender, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|July 22, 1998
Molecular mechanisms of TNF receptor-mediated signalingN P Malek, J Pluempe, S Kubicka, et al.The Journal of Biological Chemistry|November 5, 1999
p53 represses CAAT enhancer-binding protein (C/EBP)-dependent transcription of the albumin gene. A molecular mechanism involved in viral liver infection with implications for hepatocarcinogenesisS Kubicka, F Kühnel, L Zender, et al.The Journal of Biological Chemistry|February 29, 2000
NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitisF Kühnel, L Zender, Y Paul, et al.Cancer Gene Therapy|November 4, 2000
IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomasM K Tietze, T Wuestefeld, Y Paul, et al.Gut|October 18, 2005
Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intakeB Mundt, T Wirth, L Zender, et al.Pageof 10